Global Precision Medicine Market Forecast 2018-2028 - Visiongain Report

LONDON, March 29, 2018 /PRNewswire/ --

Companion Diagnostics, Biomarker-based Test, Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics, Pharmaceuticals & Biotechnology Companies, Diagnostic Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Diseases

Report Details

The global precision medicine market is expected to grow at an estimated CAGR of 12.08% from 2018 to 2028. The diagnostic tool companies segment is dominating the global market and accounted for $15,974.4 million in 2017 due to the increasing demand for diagnostic and genetic tests.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 233-page report you will receive 116 tables and 56 figures- all unavailable elsewhere.

The 233-page report provides clear detailed insight into the global precision medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope 

• Global Precision Medicine Market forecasts  from 2018-2028

• Along with revenue prediction for the overall market for the global precision medicine market, our investigation shows forecasts to 2028 for the market segmented by technology:
• Companion Diagnostics
• Biomarker-based Test
• Targeted Therapeutics
• Pharmacogenomics
• Molecular Diagnostics

The forecast for each market segment is further broken down by ecosystem player and therapeutic application

For each segment, the report discusses key trends, developments and participants.

• This report breaks down the precision medicine market forecast to 2028 by ecosystem players:
• Pharmaceuticals & Biotechnology Companies
• Diagnostic Companies
• Healthcare IT/Big Data Companies
• Clinical Laboratories

The forecast for each market segment is further broken down by technology, therapeutic application and geography.

For each segment, the report discusses key trends, developments and participants.

• This report also breaks down the precision medicine market forecast to 2028 by therapeutic application:
• Cancer
• Cardiovascular Diseases
• Central Nervous System
• Infectious Diseases

The forecast for each market segment is further broken down by ecosystem player, technology and geography.

For each segment, the report discusses key trends, developments and participants.

• This study provides precision medicine market forecasts to 2028 for these regional markets:
• The Americas
• Europe
• Asia-Pacific
• RoW

The forecast for each regional market is further broken down by ecosystem player and therapeutic application

For each regional market, the report discusses key trends, developments and participants.

• This report profiles selected leading companies that are the main players in the global precision medicine market:
• Abbott Laboratories
• GE Healthcare
• GlaxoSmithKline (GSK)
• Johnson & Johnson
• Pfizer
• Laboratories Corporation of America Holdings
• Danaher Corporation

• Our study discusses the drivers, restraints as well as the opportunities in the global precision medicine market.

• This study also analyzed the global precision medicine market with Porter's Five Forces Analysis as well as Value Chain Analysis

• This report discusses selected market developments in the precision medicine market: partnership, collaboration, join venture, acquisitions, product launch, product development, expansions, patents, approvals.

Visiongain's study is intended for anyone requiring commercial analyses for the global precision medicine market. You find data, trends and predictions.

Buy our report today Global Precision Medicine Market Forecast 2018-2028: Companion Diagnostics, Biomarker-based Test, Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics, Pharmaceuticals & Biotechnology Companies, Diagnostic Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Diseases.

To request a report overview of this report, please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100

Or click on: https://www.visiongain.com/Report/2154/Global-Precision-Medicine-Market-Forecast-2018-2028

List of Companies Mentioned in the Report: 

23andMe

Abbott

Abbott Molecular Inc.

Abcodia

ACS Biomarker

Actelion Pharmaceuticals Ltd.

Advanced Biological Laboratories

Affymetrix, Inc.

Agendia BV

Alberta Cancer Research Biobank

Alberta Health Services

Alberta Tumour Bank

Alios BioPharma, Inc.,

Almac Diagnostics

Almac Group

Apple

Archimedes,

Asurage, Inc.

AT&T

Athena Diagnostics

Athena Health, Inc.

Aurora

Auspex Pharmaceuticals, Inc.

Aventor

BGI Tech Solutions Co., Ltd.

Biobank Japan-Riken Institute

Biobanque de Picardie

BioFortis

BioGene

Biological Resources Centres

BioMérieux

Biotype Diagnostics

Bode Technology Group, Inc.

Canadian Biosample Repository

Cancer Research Network of the FRSQ

Capital Health/Regional Tissue Bank

CareWell Urgent Care

Caris Life Sciences

Celera Diagnostics

Cell& Co Biorepository

Central Biomaterial Bank

Cepheid

CFR Pharmaceuticals

Charité-Universitätsmedizin Berlin

Cognizant

Confederation of Cancer Biobanks

Continua Health Alliance

Cooperative Human Tissue Network

COPAN

Covance Inc.

Cubist Pharmaceuticals

Dako

Danubian Biobank Consortium Tissue Bank

Dell

Eagle Pharmaceuticals, Inc.

Emulate Inc.

Epizyme

Estonian Genome Project

Ferring Pharmaceuticals

Fisher BioServices

Foundation Medicine

GE Healthcare

Genethon DNA and Cell Bank

Genome Medicine

Genomics Inc.

GenoSpace

Gen-Probe, Inc.

German Heart Failure Network

Glooko

Google

Guangzhou RiboBio Co.

Hologic, Inc.

Human Tissue Resource Network

HUNT Biobank

IBM

Idera Pharmaceuticals Inc.

Illumina, Inc

Immuneering Corporation

Infectio Diagnostic, Inc.

Institutional Biobank of Lausanne

Intel

Intomics

Janssen Biotech Inc.

Japan Post Group

Japanese Collection of Research Bioresources

Johnson & Johnson

King's College Inectious Diseases Biobank

Lab-Ally LLC

Laboratory Corporation of America

LG

Life technologies

Liverpool Tissue Bank

Luminex Molecular Diagnostics, Inc.

Lutron Electronics

Manitoba Breast Tumour Bank

Mayo clinic

Medpace CRO Clinical Trial Services

Medtronic plc

Modul-Bio

Molecular Health

Monogrom Bioscience

Myriad Genetic Laboratories, Inc.

Nanosphere, Inc.

NanoString

National Health Laboratories Incorporated

NHS Cod Blood Bank

Novartis de Colombia S.A.

Omnyx, LLC

OncoMed Pharmaceuticals. Inc.

Ontario Cancer Research Network

Oracle healthcare

Organovo

Panasonic Healthcare

PATH Biobank

Patient DNA collection at Institute of Human Genetics Heidelberg

Pfizer

Pfizer's Centers for Therapeutic Innovation (CTI)

Philips Healthcare

Prasco Laboratories

Precision for Medicine

PROCURE Quebec Prostate Cancer

ProMedDx

Q2 Solutions

Qiagen

Qiagen Manchester, Ltd.

Qualcomm

Qualcomm Life, Inc.

Quartz bio

Quest Diagnostics

Randox Laboratories

Randox Toxicology

Roche

Roche Molecular Systems, Inc.

Royal Philips

Samsung

Sanofi Aventis

Siemens Clinical Lab

Signature Diagnostics AG (Signature)

Southwest France Tumour Bank

St. Jude Medical

Sterand Plc

Syapse

Sysmex

Takeda

Teva Pharmaceuticals

Therascreen

Topera, Inc.

Tumour Bank of Provence

Ventana Medical Systems, Inc.

Veropharm

Vysis

Zinfandel Pharmaceuticals

To see a report overview please email Sara Peerun on [email protected]

SOURCE Visiongain